LBA9508Background: Optimal first line therapy for patients with metastatic melanoma is an immunotherapy regimen containing an anti-PD1 antibody, regardless of tumour BRAF mutation status. Anti-PD1 ...

Despite significant improvements in survival of patients with multiple myeloma (MM), outcomes remain heterogeneous, and a significant proportion of patients experience suboptimal outcomes. Importantly ...

This study used the latest data of Global Burden of Disease (GBD) 2021 to comprehensively analyze the burden of breast cancer among older adults (age >65 years) in Asian countries.

Nivolumab plus relatlimab vs nivolumab alone for the adjuvant treatment of completely resected stage III–IV melanoma: Primary results from RELATIVITY-098.

LBA3Background: PV is characterized by red blood cell overproduction. Rusfertide is a subcutaneous (SC), self-injected, first-in-class peptide hepcidin mimetic that decreases erythrocytosis. VERIFY ...

PURPOSEAs the complexity and need for cancer care services continue to grow, time to treatment initiation (TTI) has been increasing across cancer types. Presently there are no comprehensive analyses ...

The Veterans Affairs Health Administration (VA) has experience using telehealth (TH) to deliver care to 10 million enrolled Veterans for many clinical care needs. The VA National TeleOncology Service ...

Frustrations regarding the costs and difficulties with parking at hospitals is a common concern voiced by patients, families, and healthcare providers. Transportation barriers to receiving cancer care ...

Incidence of venous thromboembolism (VTE) events in patients with EGFR-mutant non-small cell lung cancer (NSCLC) treated with amivantamab: A systematic review and combined meta-analysis of phase 3 ...

The authors noted the limitations of the study. Most importantly, use of Epic and other EHRs does not easily allow for tracking of care outside of a network or health care system. This is particularly ...

Cancer causes distress and isolation. Peer connection offers a chance for expression and validation in ways that can support patients and also oncology care providers.

The cancer fusionome and overexpressed druggable oncogenic signals in K-RAS wild-type pancreatic cancer. Delivery of B7H3-targeted CAR-T cells in injectable silk hydrogels and effects on the efficacy ...